Infecciones oculares | 11 MAY 15

Recomendaciones sobre infecciones por staphylococcus aureus resistente a meticilina

Revisión de la literatura y descripción del desafío que suponen las infecciones oculares por Staphylococcus aureus resistente a meticilina (MRSA). Recomendaciones para identificar, tratar y reducir su incidencia.

Autor/a: Francis S. Mah, MD, Richard Davidson, MD, Edward J. Holland, MD, John Hovanesian, MD, Thomas John, MD, John Kanellopoulos, MD, Neda Shamie, MD, Christopher Starr, MD, David Vroman, MD & Terry Kim, MD. J Cataract Refract Surg 2014; 40:1894–1908

INDICE: 1. Desarrollo | 2. Desarrollo

Desarrollo

1. Mah FS. New antibiotics for bacterial infections. Ophthalmol Clin North Am 2003; 16(1):11–27
2. Ogston A. “On abscesses.” [Classics in infectious diseases].Rev Infect Dis 1984; 6:122–128
3. Kluytmans J, van Belkum A, Verbrugh H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev 1997; 10:505–520. Available at: http://www.ncbi.nlm.nih.gov/pmc/
articles/PMC172932/pdf/100505.pdf. Accessed July 8, 2014
4. U.S. National Institutes of Health. Experimental staph vaccine broadly protective in animal studies. NIH news release. Embargoed for release May 27, 1999. Available at: http://www.nih. gov/news/pr/may99/niaid-27.htm. Accessed July 8, 2014
5. Jevons MP. “Celbenin”-resistant staphylococci [letter]. BMJ 1961; 1:124–125. replies by GN Rolinson, R Knox, 125–126. Available at: http://www.ncbi.nlm.nih. gov/pmc/articles/PMC1952888/pdf/brmedj02876-0102b.pdf. Replies available at: http://www.ncbi.nlm.nih.gov/pmc/ articles/PMC1952878/pdf/br
medj02876-0103.pdf. Accessed July 8, 2014
6. Chambers HF. The changing epidemiology of Staphylococcus aureus. Emerg Infect Dis 2001; 7:178–182. Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2631711/pdf/11294 701.pdf